Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 28.33M 31.88M 26.41M 24.08M 45.43M 3.07B 45.83M 320M 124M 1.57B 120M 117M 5.03B | P/E 2026 * |
-6.43x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 28.33M 31.88M 26.41M 24.08M 45.43M 3.07B 45.83M 320M 124M 1.57B 120M 117M 5.03B | EV / Sales 2026 * |
9.44x | EV / Sales 2027 * | 2.83x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 01/01/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 32.25M | |
| -0.61% | -3.30% | +38.46% | +112.77% | 1,025B | |
| -1.02% | -5.41% | +37.61% | +64.39% | 623B | |
| +1.11% | -0.87% | +7.55% | +76.32% | 459B | |
| +0.34% | -2.49% | +60.10% | +40.17% | 355B | |
| -0.95% | -4.87% | +22.46% | +38.03% | 336B | |
| -1.46% | -2.20% | +11.84% | +23.94% | 270B | |
| -1.35% | -4.27% | -4.55% | +6.92% | 247B | |
| -1.04% | -0.74% | +35.02% | +49.96% | 220B | |
| -1.87% | -3.31% | +30.22% | +93.14% | 183B | |
| Average | -1.10% | -1.89% | +26.52% | +56.18% | 413.14B | |
| Weighted average by Cap. | -0.12% | -2.11% | +29.72% | +68.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.38M 2.8M 2.55M 4.81M 325M 4.85M 33.9M 13.14M 166M 12.67M 12.4M 533M | 10M 11.25M 9.32M 8.5M 16.03M 1.08B 16.18M 113M 43.81M 553M 42.24M 41.32M 1.78B |
| Net income | -5M -5.63M -4.66M -4.25M -8.02M -542M -8.09M -56.5M -21.9M -276M -21.12M -20.66M -888M | 2M 2.25M 1.86M 1.7M 3.21M 217M 3.24M 22.6M 8.76M 111M 8.45M 8.26M 355M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
